Showing 65,341 - 65,360 results of 104,605 for search '(( 5 ((mean decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (nn decrease)) ))', query time: 1.19s Refine Results
  1. 65341

    Characteristics induced by 2 weeks exposure of SRA01/04 cells to low-doses of H<sub>2</sub>O<sub>2</sub>. by Zi-Feng Zhang (341807)

    Published 2013
    “…<p>A. Shows that cell viability (Left) of SRA01/04 cells decreases with increasing concentrations of H<sub>2</sub>O<sub>2</sub> as measured by the MTT assay (Mean± SD; n = 5.). …”
  2. 65342

    Early Wnt/β-catenin signaling enhances cardiac differentiation. by Sharon L. Paige (247316)

    Published 2010
    “…<p>(<b>A</b>) Quantitative RT-PCR on day 14 of differentiation shows induction of <i>β-MHC, cTnT and Nkx2.5</i> expression by activin A/BMP4 is attenuated with Dkk1. …”
  3. 65343

    Continental and global effects of different Δ<em>T</em><sub>g</sub> levels by Dieter Gerten (557088)

    Published 2013
    “…Projections are based on a new, consistent set of 152 climate scenarios (eight Δ<em>T</em><sub>g</sub> trajectories reaching 1.55 ° C above pre-industrial levels by 2100, each scaled with spatial patterns from 19 general circulation models). …”
  4. 65344

    Data Sheet 1_Valve-in-valve transcatheter aortic valve replacement (TAVR) leads to lower device success compared to TAVR in native stenosis.pdf by Michael Paukovitsch (16428786)

    Published 2025
    “…While ViV-TAVR decreased peak and mean gradients significantly, in 31% of patients elevated mean gradients (≥20 mmHg) were observed at discharge. …”
  5. 65345
  6. 65346
  7. 65347
  8. 65348
  9. 65349
  10. 65350
  11. 65351
  12. 65352
  13. 65353

    An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing by Raymond W. Wong (8463498)

    Published 2020
    “…<div><p>The ability of HIV-1 to evolve resistance to combined antiretroviral therapies (cARTs) has stimulated research into alternative means of controlling this infection. We assayed >60 modulators of RNA alternative splicing (AS) to identify new inhibitors of HIV-1 RNA processing—a segment of the viral lifecycle not targeted by current drugs—and discovered compound N-[4-chloro-3-(trifluoromethyl)phenyl]-7-nitro-2,1,3-benzoxadiazol-4-amine (5342191) as a potent inhibitor of both wild-type (<i>Ba-L</i>, <i>NL4-3</i>, <i>LAI</i>, <i>IIIB</i>, and <i>N54</i>) and drug-resistant strains of HIV-1 (IC<sub>50</sub>: ~700 nM) with no significant effect on cell viability at doses tested. 5342191 blocks expression of four essential HIV-1 structural and regulatory proteins (Gag, Env, Tat, and Rev) without affecting total protein synthesis of the cell. …”
  14. 65354
  15. 65355

    Post-injury berberine treatment attenuated brain edema, blood-brain barrier (BBB) permeability, matrix metalloproteinase (MMP)-9 enzymatic activity, neutrophil infiltration and ICA... by Chien-Cheng Chen (207053)

    Published 2014
    “…<p>Berberine (10 mg·kg<sup>−1</sup>) significantly decreased (<b>A</b>) brain water content and (<b>B</b>) leakage of Evans Blue into the brain and in the ipsilateral hemisphere compared with the vehicle-treated mice. …”
  16. 65356

    Image 4_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

    Published 2025
    “…The most common AEs in the PC group were blood toxicity related AEs (anemia, neutrophil count decreased, etc).</p>Conclusion<p>The PC therapy continues to provide a substantial survival benefit for patients with stage IIIb-IV NSCLC. …”
  17. 65357

    Table 4_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

    Published 2025
    “…The most common AEs in the PC group were blood toxicity related AEs (anemia, neutrophil count decreased, etc).</p>Conclusion<p>The PC therapy continues to provide a substantial survival benefit for patients with stage IIIb-IV NSCLC. …”
  18. 65358

    Image 1_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

    Published 2025
    “…The most common AEs in the PC group were blood toxicity related AEs (anemia, neutrophil count decreased, etc).</p>Conclusion<p>The PC therapy continues to provide a substantial survival benefit for patients with stage IIIb-IV NSCLC. …”
  19. 65359

    Image 8_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

    Published 2025
    “…The most common AEs in the PC group were blood toxicity related AEs (anemia, neutrophil count decreased, etc).</p>Conclusion<p>The PC therapy continues to provide a substantial survival benefit for patients with stage IIIb-IV NSCLC. …”
  20. 65360

    Image 2_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

    Published 2025
    “…The most common AEs in the PC group were blood toxicity related AEs (anemia, neutrophil count decreased, etc).</p>Conclusion<p>The PC therapy continues to provide a substantial survival benefit for patients with stage IIIb-IV NSCLC. …”